UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 75

Sortiert nach

A cross-sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitis

Rheumatology (Oxford, England), 2011-05, Vol.50 (5), p.899-905

2011

Volltextzugriff (PDF)

Real world analysis of high-cut-off (HCO) hemodialysis with bortezomib-based backbone therapy in patients with multiple myeloma and acute kidney injury

Journal of nephrology, 2021-08, Vol.34 (4), p.1263-1270

2021

Volltextzugriff (PDF)

Serum Hepcidin Is Increased in ANCA-Associated Vasculitis and Correlates With Activity Markers

Physiological research, 2018-01, Vol.67 (6), p.945-954

2018

Volltextzugriff (PDF)

Long-term outcome of severe alveolar haemorrhage in ANCA-associated vasculitis: a retrospective cohort study

Scandinavian journal of rheumatology, 2013-01, Vol.42 (3), p.211-214

2013

Volltextzugriff (PDF)

Increased Levels of Soluble ST2 in Patients with Active Newly Diagnosed ANCA-Associated Vasculitis

Mediators of Inflammation, 2015-01, Vol.2015 (1), p.603750-603750

2015

Volltextzugriff (PDF)

Matrix Metalloproteinases and Their Tissue Inhibitors: an Evaluation of Novel Biomarkers in ANCA-Associated Vasculitis

Folia biologica, 2019-01, Vol.65 (5-6), p.227-236

2019

Volltextzugriff (PDF)

AB0177 Toll-Like Receptors - Differences between Healthy Control, ANCA Associated Vasculitis and Lupus Kindeys - Preliminary Pilot Study

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.861-861

2014

Volltextzugriff (PDF)

Rituximab use in patients with ANCA-associated vasculitis: clinical efficacy and impact on immunological parameters

Clinical rheumatology, 2015-01, Vol.34 (1), p.107-115

2015

Volltextzugriff (PDF)

Brain diffuse large B-cell lymphoma in a systemic lupus erythematosus patient treated with immunosuppressive agents including mycophenolate mofetil

Lupus, 2011-11, Vol.20 (13), p.1452-1454

2011

Volltextzugriff (PDF)

SAT0265 Characteristics and Outcomes of Patients with Anca-Associated Vasculitis (AAV) in the Czech Population

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.689-689

2014

Volltextzugriff (PDF)

Recent news in the treatment of lupus nephritis

Minerva medica, 2012-08, Vol.103 (4), p.235

2012

Volltextzugriff (PDF)

Reduced number of endothelial progenitor cells is predictive of early relapse in anti-neutrophil cytoplasmic antibody-associated vasculitis

Rheumatology (Oxford, England), 2009-10, Vol.48 (10), p.1197-1201

2009

Volltextzugriff (PDF)

Renal transplantation in anti-neutrophil cytoplasmic antibody-associated vasculitis

Nephrology, dialysis, transplantation, 2015-04, Vol.30 Suppl 1, p.i159-i163

2015

Volltextzugriff (PDF)

Novel flow cytometric method for the detection of podocalyxin-positive elements in urine of patients with glomerulonephritides - first promising results

Folia biologica, 2012-01, Vol.58 (2), p.57-63

2012

Volltextzugriff (PDF)

Predictors of hypogammaglobulinemia in ANCA-associated vasculitis after a rituximab-based induction: a multicentre study

Rheumatology (Oxford, England), 2023-08, Vol.62 (8), p.2850-2854

2023

Volltextzugriff (PDF)

Outcome and treatment of elderly patients with ANCA-associated vasculitis

Clinical journal of the American Society of Nephrology, 2015-07, Vol.10 (7), p.1128-1135

2015

Volltextzugriff (PDF)

Application of omics approaches to study urinary biomarkers in ANCA - Associated vasculitides

Clinica chimica acta, 2019-06, Vol.493, p.S5-S6

2019

Volltextzugriff (PDF)

P1359 Left ventricle hypertrophy and diastolic dysfunction in haemodialysis patients after surgical reduction of arteriovenous fistula blood flow

European heart journal cardiovascular imaging, 2020-01, Vol.21 (Supplement_1)

2020

Volltextzugriff (PDF)

Association of a TNFSF13B (BAFF) regulatory region single nucleotide polymorphism with response to rituximab in antineutrophil cytoplasmic antibody–associated vasculitis

Journal of allergy and clinical immunology, 2017-05, Vol.139 (5), p.1684-1687.e10

2017

Volltextzugriff (PDF)

Repeat protocol renal biopsy in ANCA-associated renal vasculitis

Nephrology, dialysis, transplantation, 2014-09, Vol.29 (9), p.1728-1732

2014

Volltextzugriff (PDF)

SAT-389 INCIDENCE AND OUTCOME OF PATIENTS STARTING RENAL REPLACEMENT THERAPY FOR END-STAGE RENAL DISEASE DUE TO SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM THE ERA-EDTA REGISTRY

Kidney international reports, 2020-03, Vol.5 (3), p.S163-S163

2020

Volltextzugriff (PDF)

Measurement of damage in systemic vasculitis: a comparison of the Vasculitis Damage Index with the Combined Damage Assessment Index

Annals of the rheumatic diseases, 2011-01, Vol.70 (1), p.80-85

2011

Volltextzugriff (PDF)

SUN-150 BIOMARKERS MAY PREDICT THE SEVERITY AND OUTCOME OF RENAL AAV

Kidney international reports, 2020-03, Vol.5 (3), p.S262-S262

2020

Volltextzugriff (PDF)

1 – 25 von 75

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(68)
Mit Volltextzugriff
(60)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A cross-sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitis

Real world analysis of high-cut-off (HCO) hemodialysis with bortezomib-based backbone therapy in patients with multiple myeloma and acute kidney injury

Serum Hepcidin Is Increased in ANCA-Associated Vasculitis and Correlates With Activity Markers

Long-term outcome of severe alveolar haemorrhage in ANCA-associated vasculitis: a retrospective cohort study

Increased Levels of Soluble ST2 in Patients with Active Newly Diagnosed ANCA-Associated Vasculitis

Matrix Metalloproteinases and Their Tissue Inhibitors: an Evaluation of Novel Biomarkers in ANCA-Associated Vasculitis

AB0177 Toll-Like Receptors - Differences between Healthy Control, ANCA Associated Vasculitis and Lupus Kindeys - Preliminary Pilot Study

Rituximab use in patients with ANCA-associated vasculitis: clinical efficacy and impact on immunological parameters

Brain diffuse large B-cell lymphoma in a systemic lupus erythematosus patient treated with immunosuppressive agents including mycophenolate mofetil

SAT0265 Characteristics and Outcomes of Patients with Anca-Associated Vasculitis (AAV) in the Czech Population

Recent news in the treatment of lupus nephritis

Reduced number of endothelial progenitor cells is predictive of early relapse in anti-neutrophil cytoplasmic antibody-associated vasculitis

Genetically Distinct Subsets within ANCA-Associated Vasculitis

Renal transplantation in anti-neutrophil cytoplasmic antibody-associated vasculitis

Novel flow cytometric method for the detection of podocalyxin-positive elements in urine of patients with glomerulonephritides - first promising results

Predictors of hypogammaglobulinemia in ANCA-associated vasculitis after a rituximab-based induction: a multicentre study

Outcome and treatment of elderly patients with ANCA-associated vasculitis

Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?

Application of omics approaches to study urinary biomarkers in ANCA - Associated vasculitides

P1359 Left ventricle hypertrophy and diastolic dysfunction in haemodialysis patients after surgical reduction of arteriovenous fistula blood flow

Association of a TNFSF13B (BAFF) regulatory region single nucleotide polymorphism with response to rituximab in antineutrophil cytoplasmic antibody–associated vasculitis

Repeat protocol renal biopsy in ANCA-associated renal vasculitis

SAT-389 INCIDENCE AND OUTCOME OF PATIENTS STARTING RENAL REPLACEMENT THERAPY FOR END-STAGE RENAL DISEASE DUE TO SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM THE ERA-EDTA REGISTRY

Measurement of damage in systemic vasculitis: a comparison of the Vasculitis Damage Index with the Combined Damage Assessment Index

SUN-150 BIOMARKERS MAY PREDICT THE SEVERITY AND OUTCOME OF RENAL AAV

Suchergebnisse filtern